abrdn World Healthcare Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2015-06-26. abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt securities of public and private United States and non-United States companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, healthcare distributors, and others. The Fund’s investment adviser is abrdn Inc.
根據最新的財務報表(Form-10K),abrdn World Healthcare Fund 的總資產為 $637,淨利潤為 $55
THW 的關鍵財務比率是什麼?
abrdn World Healthcare Fund 的流動比率為 5.13,淨利潤率為 500,每股銷售為 $0.27。
abrdn World Healthcare Fund 的收入按細分市場或地理位置如何劃分?
abrdn World Healthcare Fund 最大收入來源為 Bar,在最近的收益報告中收入為 1,167,450,000。就地區而言,United Kingdom and Ireland 是 abrdn World Healthcare Fund 的主要市場,收入為 2,035,500,000。
abrdn World Healthcare Fund 是否盈利?
是的,根據最新的財務報表,abrdn World Healthcare Fund 的淨利潤為 $55